FierceBiotech 2025-12-04 FDA names Tracy Beth Høeg, fresh from vaccine safety probe, as acting head of drug center
FierceBiotech 2025-12-04 FDA floats user fee cuts for early-stage US trials, additional fees for overseas development
FierceBiotech 2025-12-03 Capricor's phase 3 win sets up 2nd approval attempt for Duchenne cell therapy
FierceBiotech 2025-12-03 Fierce Biotech Fundraising Tracker '25: Triana glues $120M series B; Protego raises $130M
FierceBiotech 2025-12-03 With site 'irregularities,' Bristol Myers delays key Cobenfy readout in Alzheimer's psychosis
FierceBiotech 2025-12-03 Pfizer-backed Triana scores $120M series B to take molecular glue degrader into clinic
FierceBiotech 2025-12-02 Janux T-cell engager data sink stock, but analysts still see best-in-class potential
FierceBiotech 2025-12-02 Boston Scientific claims European approval for Farapoint focal pulsed field ablation catheter
FierceBiotech 2025-12-02 Imvax takes brain cancer cell therapy to FDA, betting survival hit will overshadow primary miss
FierceBiotech 2025-12-02 Tiziana to spin out IL-6 drug into new company, citing Big Pharma's interest in modality
FierceBiotech 2025-12-02 Roche's point-of-care whooping cough test greenlighted in US, Europe as cases surge
FierceBiotech 2025-12-02 FDA adopts agentic AI in latest push to infuse artificial intelligence into agency